In last trading session, Beta Bionics Inc (NASDAQ:BBNX) saw 0.86 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $9.91 trading at -$0.86 or -7.99% at ring of the bell on the day assigns it a market valuation of $429.60M. That closing price of BBNX’s stock is at a discount of -147.23% from its 52-week high price of $24.50 and is indicating a discount of -7.27% from its 52-week low price of $10.63. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.69 million shares which gives us an average trading volume of 653.65K if we extend that period to 3-months.
Beta Bionics Inc (NASDAQ:BBNX) trade information
Upright in the red during last session for losing -7.99%, in the last five days BBNX remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $9.91 price level, adding 21.16% to its value on the day. Beta Bionics Inc’s shares saw a change of -58.06% in year-to-date performance and have moved -15.37% in past 5-day. Beta Bionics Inc (NASDAQ:BBNX) showed a performance of -44.36% in past 30-days. Number of shares sold short was 1.21 million shares which calculate 3.43 days to cover the short interests.
Beta Bionics Inc (BBNX) estimates and forecasts
This year revenue growth is estimated to rise 26.87% from the last financial year’s standing.
7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 16.15M for the same. And 7 analysts are in estimates of company making revenue of 19.26M in the next quarter.
In 2025, company’s earnings growth rate is likely to be around 78.64% while estimates for its earnings growth in next 5 years are of 38.22%.
Beta Bionics Inc (NASDAQ:BBNX)’s Major holders
Insiders are in possession of 6.84% of company’s total shares while institution are holding 51.93 percent of that, with stock having share float percentage of 55.75%. Investors also watch the number of corporate investors in a company very closely, which is 51.93% institutions for Beta Bionics Inc that are currently holding shares of the company.
